Works by Yamazaki, Kentaro
Results: 143
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Bacterial species-characteristic profiles of molecular species, and the antigenicity of phospholipids and glycolipids in symbiotic Lactobacillus, Staphylococcus and Streptococcus species.
- Published in:
- Glycoconjugate Journal, 2012, v. 29, n. 4, p. 199, doi. 10.1007/s10719-012-9393-2
- By:
- Publication type:
- Article
Potential effect on cellular response to cadmium of a single-nucleotide A → G polymorphism in the promoter of the human gene for metallothionein IIA.
- Published in:
- Human Genetics, 2006, v. 120, n. 4, p. 553, doi. 10.1007/s00439-006-0238-6
- By:
- Publication type:
- Article
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing.
- Published in:
- Biomedical Reports, 2019, v. 11, n. 4, p. 171, doi. 10.3892/br.2019.1235
- By:
- Publication type:
- Article
Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 01, doi. 10.3389/fcimb.2022.925444
- By:
- Publication type:
- Article
Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?
- Published in:
- ISRN Oncology, 2012, p. 1, doi. 10.5402/2012/274739
- By:
- Publication type:
- Article
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 859, doi. 10.1093/jjco/hyaa042
- By:
- Publication type:
- Article
Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 2, p. 122, doi. 10.1093/jjco/hyz149
- By:
- Publication type:
- Article
Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 910, doi. 10.1093/jjco/hyz089
- By:
- Publication type:
- Article
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 11, p. 2184, doi. 10.1002/cam4.4599
- By:
- Publication type:
- Article
Development of a nomogram to predict survival in advanced biliary tract cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48889-6
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.
- Published in:
- Current Medical Research & Opinion, 2021, v. 37, n. 10, p. 1769, doi. 10.1080/03007995.2021.1940908
- By:
- Publication type:
- Article
Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.
- Published in:
- BMC Palliative Care, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12904-024-01538-9
- By:
- Publication type:
- Article
Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 6, p. 469, doi. 10.1007/s00280-023-04527-6
- By:
- Publication type:
- Article
Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
- Published in:
- Oncology, 2019, v. 96, n. 3, p. 132, doi. 10.1159/000493321
- By:
- Publication type:
- Article
Case of shaken baby syndrome in Japan caused by shaking alone.
- Published in:
- Pediatrics International, 2003, v. 45, n. 1, p. 117, doi. 10.1046/j.1442-200X.2003.01653.x
- By:
- Publication type:
- Article
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis Inhibitor.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tempo and mode of evolution of the Rh blood group genes before and after gene duplication.
- Published in:
- Immunogenetics, 2007, v. 59, n. 5, p. 427, doi. 10.1007/s00251-007-0204-z
- By:
- Publication type:
- Article
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS: MSI-high unresectable gastric cancer...: A. Komori et al.
- Published in:
- Gastric Cancer, 2025, v. 28, n. 2, p. 301, doi. 10.1007/s10120-024-01579-2
- By:
- Publication type:
- Article
Role of hepatectomy in gastric cancer with multiple liver-limited metastases.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 2, p. 338, doi. 10.1007/s10120-017-0730-9
- By:
- Publication type:
- Article
Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 894, doi. 10.1007/s10120-015-0540-x
- By:
- Publication type:
- Article
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2010, v. 13, n. 4, p. 245, doi. 10.1007/s10120-010-0566-z
- By:
- Publication type:
- Article
Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.
- Published in:
- Gastric Cancer, 2009, v. 12, n. 4, p. 206, doi. 10.1007/s10120-009-0524-9
- By:
- Publication type:
- Article
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.
- Published in:
- Gastric Cancer, 2009, v. 12, n. 3, p. 153, doi. 10.1007/s10120-009-0517-8
- By:
- Publication type:
- Article
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 1029, doi. 10.3892/mco.2015.586
- By:
- Publication type:
- Article
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11311-5
- By:
- Publication type:
- Article
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11199-1
- By:
- Publication type:
- Article
Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 6, p. 1037, doi. 10.1007/s10147-014-0662-x
- By:
- Publication type:
- Article
Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 5, p. 864, doi. 10.1007/s10147-012-0452-2
- By:
- Publication type:
- Article
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 2, p. 279, doi. 10.1007/s10147-012-0374-z
- By:
- Publication type:
- Article
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 10, doi. 10.1007/s10147-011-0335-y
- By:
- Publication type:
- Article
Leptomeningeal carcinomatosis associated with gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 361, doi. 10.1007/s10147-011-0301-8
- By:
- Publication type:
- Article
Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 359, doi. 10.1007/s10147-011-0192-8
- By:
- Publication type:
- Article
Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.
- Published in:
- International Journal of Clinical Oncology, 2010, v. 15, n. 3, p. 287, doi. 10.1007/s10147-010-0054-9
- By:
- Publication type:
- Article
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 6, p. 513, doi. 10.1007/s10147-009-0911-6
- By:
- Publication type:
- Article
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 150, doi. 10.1007/s10147-007-0738-y
- By:
- Publication type:
- Article
Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
- Published in:
- International Journal of Clinical Oncology, 2005, v. 10, n. 6, p. 429, doi. 10.1007/s10147-005-0502-0
- By:
- Publication type:
- Article
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 595, doi. 10.1007/s00432-012-1349-1
- By:
- Publication type:
- Article
The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis.
- Published in:
- World Journal of Surgery, 2020, v. 44, n. 4, p. 1231, doi. 10.1007/s00268-019-05326-y
- By:
- Publication type:
- Article